Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Journal of Chemotherapy (Florence, Italy)|April 15, 2005
Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, TurkeyB Sener, O Köseoglu, D Gür, et al.
Pathologie-Biologie|May 1, 1985
[Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin]L Dubreuil, J Devos, C Romond, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1995
In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondiiS Romand, A Bryskier, M Moutot, et al.
Annales Pharmaceutiques Francaises|January 1, 1990
[Preparation of monodesethylamodiaquine from human urine]S Ménager, O Lafont, P Chrétien, et al.
Pathologie-Biologie|May 1, 1986
[In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes]L Dubreuil, J Devos, C Romond, et al.
Pathologie-Biologie|May 1, 1985
[In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]P Le Noc, A Bryskier, D Le Noc
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1985
Ofloxacin: antibacterial activity, induction of resistance and killing curvesM O Husson, D Izard, A Bryskier, et al.
Pathologie-Biologie|June 1, 1985
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]J Croize, P Le Noc, A Bryskier, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4N Rastogi, K S Goh, M Berchel, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineN Rastogi, K S Goh, A Bryskier, et al.
Pageof 12